Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. OCTP.L Share Price
  4. OCTP.L Share Regulatory News

Pin to quick picksOCTP.L Regulatory News (OCTP)

OCTP.L Information
  • There is currently no data for OCTP
123
Date   Source Headline
6th Mar 202311:05 amRNSSecond Price Monitoring Extn
6th Mar 202311:00 amRNSPrice Monitoring Extension
25th Jan 202312:09 pmRNSHolding in Company
23rd Jan 20237:00 amRNSHalf-year Report
16th Jan 20237:00 amRNSAppointment of General Counsel & Notice of Results
12th Jan 20237:00 amRNSUpdate on combined Clinical Trial Application
5th Jan 202310:46 amRNSSubmission of combined Clinical Trial Application
4th Jan 20232:05 pmRNSSecond Price Monitoring Extn
4th Jan 20232:00 pmRNSPrice Monitoring Extension
4th Jan 202311:05 amRNSSecond Price Monitoring Extn
4th Jan 202311:00 amRNSPrice Monitoring Extension
3rd Jan 202311:05 amRNSSecond Price Monitoring Extn
3rd Jan 202311:00 amRNSPrice Monitoring Extension
29th Dec 20224:40 pmRNSSecond Price Monitoring Extn
29th Dec 20224:35 pmRNSPrice Monitoring Extension
15th Dec 20222:42 pmRNSDirector/PDMR Shareholding
15th Dec 202212:31 pmEQSProactive research analyst John Savin on Oxford Cannabinoid Technologies
15th Dec 20229:37 amEQSOxford Cannabinoid Technologies 'very confident' heading into 2023
12th Dec 20227:00 amRNSTrading Update
5th Dec 20222:39 pmEQSOxford Cannabinoid Technologies appoints new CEO
5th Dec 20227:00 amRNSDirectorate Change
15th Nov 20223:23 pmEQSOxford Cannabinoid Technologies nearly ready for new phase 1 trial
15th Nov 202211:28 amRNSHolding(s) in Company
11th Nov 202211:05 amRNSSecond Price Monitoring Extn
11th Nov 202211:00 amRNSPrice Monitoring Extension
17th Oct 20227:00 amRNSDirectorate Change
17th Oct 20227:00 amRNSDirectorate Change
28th Sep 20221:04 pmRNSResult of AGM
28th Sep 20227:00 amRNSAppointment of finnCap Ltd. as Corporate Broker
31st Aug 20227:00 amRNSNotice of AGM
26th Aug 20227:00 amRNSStrategic Budget Review & Directorate Change
15th Aug 20227:00 amRNSInaugural Meeting of Scientific Advisory Board
4th Aug 20227:00 amRNSFiling of 2022 Annual Report & Accounts
3rd Aug 202211:05 amRNSSecond Price Monitoring Extn
3rd Aug 202211:00 amRNSPrice Monitoring Extension
25th Jul 20227:00 amRNS2022 Final Results
20th Jul 20227:00 amRNSNotice of Results
20th Jul 20227:00 amRNSMSA and Work Order with Simbec Research
29th Jun 20227:00 amRNSTrading Update
30th May 20224:40 pmRNSSecond Price Monitoring Extn
30th May 20224:35 pmRNSPrice Monitoring Extension
16th May 20227:00 amRNSNew Broker and Investor Presentation
25th Apr 20227:00 amRNSFormation of Scientific Advisory Board
6th Apr 202212:58 pmRNSResults of Requisitioned General Meeting
1st Apr 20227:00 amRNSRegistered Office Address Change
31st Mar 20227:00 amRNSUpdates on Lead Programme 1 and Programme 2
11th Mar 202210:00 amRNSPosting of Circular & Notice of GM
10th Mar 202211:34 amRNSHolding in Company
8th Mar 20228:28 pmEQSData from pre-clinical study of OCT461201 shows positive results
8th Mar 20227:00 amRNSData from pre-clinical study show positive results
123

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
1RV0
Citi Fun 27
LSE
0.00%
ZAPR.US
Innovator Equity Defined Protection Etf - 1 Yr April
CBOE
0.00%
1RR0
Citi Fun 27
LSE
0.00%
RWEM.US
Rayliant Nxtgen Multifactor Emerging Markets Equity Etf
CBOE
-3.89%
PDG
PDG.L
LSE
0.00%
Trending
RRR
Red Rock Resources
LSE
0.00%
GGP
Greatland Resources
LSE
1.29%
FORG
Forgent
LSE
6.32%
FRES
Fresnillo
LSE
2.00%
GUN
Gunsynd
LSE
0.00%